Atlas Trials

Safety and Immunogenicity Study of Quadrivalent Influenza Virus Vaccine in Healthy People Aged Years 3-60

Clinical trial NCT02806804 · UNKNOWN

Trial details

NCT number
NCT02806804
Sponsor
Beijing Chaoyang District Centre for Disease Control and Prevention
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Quadrivalent Influenza Virus Vaccine
Start date
2016-05-01
Primary completion
2016-06-01
Enrollment
2400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.